Entrada Therapeutics, Inc. ( TRDA) - Key Metrics
TRDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.03 | -$0.95 | -$0.78 | -$0.77 |
| 2025Q3 | $0.04 | -$1.06 | -$0.68 | -$0.68 |
| 2025Q2 | $0.05 | -$1.04 | -$0.71 | -$0.72 |
| 2025Q1 | $0.50 | -$0.42 | -$0.94 | -$0.97 |
TRDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.71 |
| 2025Q3 | ? | -1.36 |
| 2025Q2 | ? | -1.61 |
| 2025Q1 | ? | -5.35 |
TRDA
Price: $7
52 week price:
Earnings Per Share: -4.00 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 22900
Market Capitalization: 268.4 million